Technology | September 04, 2014

DynaMed to Utilize Information from the National Comprehensive Cancer Network

September 4, 2014 — Healthcare professionals will be able to access information about the latest and most complete oncology guidelines available at the point of care following an agreement between EBSCO Health and the National Comprehensive Cancer Network (NCCN). Information from NCCN will be summarized along with other evidence and guidelines in the content available from the clinical reference tool DynaMed.

NCCN, a not-for-profit alliance of 25 of the world's leading cancer centers, is dedicated to improving the quality, effectiveness and efficiency of cancer care. Through the leadership and expertise of clinical professionals at NCCN member institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the healthcare delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians and other healthcare decision-makers.

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) document evidence-based, consensus-driven management to ensure all patients receive preventive, diagnostic, treatment and supportive services that are most likely to lead to optimal outcomes. DynaMed will be able to use these guidelines as a reference to augment the existing evidence and guidelines that it considers when updating oncology topics. The DynaMed guidelines will include citations of the NCCN Content and will show the NCCN Categories of Evidence and Consensus.

DynaMed founder and vice president for evidence-based medicine research and development, quality and standards, Brian Alper, M.D., says the addition of the NCCN Guidelines as a clinical reference will enhance the currency of DynaMed’s oncology content. “Oncology is a field that changes very quickly and being able to utilize the NCCN Guidelines is a way to ensure the oncology content in DynaMed is the most current and comprehensive,” he said.

Several studies have shown DynaMed provides the most useful information to healthcare professionals at the point of care. DynaMed ranked highest among 10 online clinical resources in a study in the Journal of Clinical Epidemiology and twice was rated highest in its category by healthcare providers in a report on clinical decision support resources by KLAS.

For more information: www.health.ebsco.com/products/dynamed/clinical-decision-support

Related Content

Effective Jan. 1, 2020, new regulations under the Centers for Medicare & Medicaid Services (CMS) Protecting Access to Medicare Act (PAMA) will require physicians to consult a CMS-approved clinical decision support mechanism before ordering advanced imaging exams for fee-for-service Medicare patients
News | Clinical Decision Support | December 26, 2019
December 26, 2019 — Effective Jan.
Videos | Radiology Business | August 02, 2019
Association for Medical Imaging Management (AHRA) President ...
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Varian Purchasing Embolic Bead Assets from Boston Scientific
News | Interventional Radiology | July 03, 2019
Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable...
Three Palm Software Releases WorkstationOne Version 1.8.8
Technology | Mammography Reporting Software | June 12, 2019
Three Palm Software announced the release of the 1.8.8 version of its breast imaging workstation, WorkstationOne. This...
Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

Pseudocolor accentuated CT scan image of a liver tumor. Image courtesy of Lucence Diagnostics.

News | Oncology Diagnostics | March 12, 2019
Genomic medicine company Lucence Diagnostics announced a new project to develop artificial intelligence (AI) algorithms...